http://120.24.161.253:5617/index.php?action=history&feed=atom&title=%E8%A7%86%E7%BD%91%E8%86%9C%E6%AF%8D%E7%BB%86%E8%83%9E%E7%98%A4-%E5%90%8C%E4%B9%89%E8%AF%8D-RB 2026-05-12T22:29:56Z 本wiki的该页面的版本历史 MediaWiki 1.30.0 http://120.24.161.253:5617/index.php?title=%E8%A7%86%E7%BD%91%E8%86%9C%E6%AF%8D%E7%BB%86%E8%83%9E%E7%98%A4-%E5%90%8C%E4%B9%89%E8%AF%8D-RB&diff=2027878&oldid=prev 2026-04-16T04:37:44Z

<p>导入1个版本</p> <table class="diff diff-contentalign-left" data-mw="interface"> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="1" style="background-color: white; color:black; text-align: center;">2026年4月16日 (四) 04:37的版本</td> </tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div> </td></tr></table>

KGadmin http://120.24.161.253:5617/index.php?title=%E8%A7%86%E7%BD%91%E8%86%9C%E6%AF%8D%E7%BB%86%E8%83%9E%E7%98%A4-%E5%90%8C%E4%B9%89%E8%AF%8D-RB&diff=2005390&oldid=prev 2026-04-15T13:15:18Z

<p>导入1个版本</p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">2026年4月15日 (三) 13:15的版本</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l5" >第5行：</td> <td colspan="2" class="diff-lineno">第5行：</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==来源==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==来源==</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>===<del class="diffchange diffchange-inline">视网膜母细胞瘤经眼动脉灌注化学药物治疗与经静脉全身化学药物治疗后摘除眼球的组织病理学特征研究</del>===</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>===<ins class="diffchange diffchange-inline">视网膜母细胞瘤分子生物学研究进展</ins>===</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">目的 探讨</del>[[视网膜母细胞瘤]]([[RB]])<del class="diffchange diffchange-inline">经眼动脉灌注化学药物治疗(IAC)或经静脉全身化学药物治疗(IVC)后摘除眼球的临床组织病理学特征。</del></div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>[[视网膜母细胞瘤]](<ins class="diffchange diffchange-inline">retinoblastoma, </ins>[[RB]])<ins class="diffchange diffchange-inline">是婴幼儿最常见的眼内恶性肿瘤,一直被认为是研究肿瘤遗传学和肿瘤发病机理的理想模式.</ins></div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>===<del class="diffchange diffchange-inline">视网膜母细胞瘤视神经侵犯影像学与病理学检查一致性分析</del>===</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>===<ins class="diffchange diffchange-inline">基质金属蛋白酶-9和血管内皮生长因子在视网膜母细胞瘤中的表达及其临床意义</ins>===</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">分析</del>[[视网膜母细胞瘤]]<del class="diffchange diffchange-inline">（</del>[[RB]]<del class="diffchange diffchange-inline">）视神经侵犯的影像学检查与临床病理学检查的一致性。</del></div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">目的:研究基质金属蛋白酶-9 (matrix metalloproteinase-9,MMP-9) 和血管内皮生长因子(vascular endothelial growth factor,VEGF)在</ins>[[视网膜母细胞瘤]]<ins class="diffchange diffchange-inline">(retinoblastoma,</ins>[[RB]]<ins class="diffchange diffchange-inline">)中</ins></div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>===<del class="diffchange diffchange-inline">房水检测在视网膜母细胞瘤诊治中的应用</del>===</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>===<ins class="diffchange diffchange-inline">视网膜母细胞瘤的临床表现和诊断</ins>===</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">摘要 </del>[[视网膜母细胞瘤]](<del class="diffchange diffchange-inline">retinoblastoma，</del>[[RB]])<del class="diffchange diffchange-inline">是儿童最常见的眼内恶性肿瘤，由于其肿瘤组织松散，活检在[[RB]]中是禁忌。</del></div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>[[视网膜母细胞瘤]]([[RB]])<ins class="diffchange diffchange-inline">是一种好发于3岁以下儿童的高度恶性眼内肿瘤,其临床表现因就诊时疾病所处的阶段不同而不同.</ins></div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>===<del class="diffchange diffchange-inline">经后交通动脉进行眼动脉灌注化疗术治疗儿童视网膜母细胞瘤的多中心经验</del>===</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>===<ins class="diffchange diffchange-inline">视网膜母细胞瘤基因治疗的研究进展</ins>===</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">目的 探索经后交通动脉进行眼动脉灌注化疗（intra</del>-<del class="diffchange diffchange-inline">arterial chemotherapy via posterior communicating artery，p</del>-<del class="diffchange diffchange-inline">IAC）在</del>[[视网膜母细胞瘤]]<del class="diffchange diffchange-inline">（retinoblastoma，</del>[[RB]]<del class="diffchange diffchange-inline">）中的可行性与安全性。</del></div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">近年来[[视网膜母细胞瘤]]([[RB]])的综合治疗越来越受到重视.</ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>&#160;</div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">===电穿孔介导质粒DNA导入视网膜母细胞瘤抑制肿瘤生长的实验研究===</ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">目的探讨电穿孔方法介导编码可溶性血管内皮细胞膜受体sFlk</ins>-<ins class="diffchange diffchange-inline">1和ExTek的真核表达质粒肿瘤内转移对[[视网膜母细胞瘤]]([[RB]])移植瘤生长的治疗效果及其作用机制.</ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>&#160;</div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">===姜黄素诱导视网膜母细胞瘤细胞株Hxo</ins>-<ins class="diffchange diffchange-inline">rb44细胞DNA损伤和细胞周期时相变化===</ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">目的 探讨姜黄素诱导</ins>[[视网膜母细胞瘤]]<ins class="diffchange diffchange-inline">(</ins>[[RB]]<ins class="diffchange diffchange-inline">)细胞株Hxo-rb44细胞DNA损伤和周期时相变化的关系.</ins></div></td></tr> </table>

KGadmin http://120.24.161.253:5617/index.php?title=%E8%A7%86%E7%BD%91%E8%86%9C%E6%AF%8D%E7%BB%86%E8%83%9E%E7%98%A4-%E5%90%8C%E4%B9%89%E8%AF%8D-RB&diff=2027877&oldid=prev 2026-04-13T13:56:59Z

<p>修改1</p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">2026年4月13日 (一) 13:56的版本</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l5" >第5行：</td> <td colspan="2" class="diff-lineno">第5行：</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==来源==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==来源==</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>===<del class="diffchange diffchange-inline">视网膜母细胞瘤分子生物学研究进展</del>===</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>===<ins class="diffchange diffchange-inline">视网膜母细胞瘤经眼动脉灌注化学药物治疗与经静脉全身化学药物治疗后摘除眼球的组织病理学特征研究</ins>===</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>[[视网膜母细胞瘤]](<del class="diffchange diffchange-inline">retinoblastoma, </del>[[RB]])<del class="diffchange diffchange-inline">是婴幼儿最常见的眼内恶性肿瘤,一直被认为是研究肿瘤遗传学和肿瘤发病机理的理想模式.</del></div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">目的 探讨</ins>[[视网膜母细胞瘤]]([[RB]])<ins class="diffchange diffchange-inline">经眼动脉灌注化学药物治疗(IAC)或经静脉全身化学药物治疗(IVC)后摘除眼球的临床组织病理学特征。</ins></div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>===<del class="diffchange diffchange-inline">基质金属蛋白酶-9和血管内皮生长因子在视网膜母细胞瘤中的表达及其临床意义</del>===</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>===<ins class="diffchange diffchange-inline">视网膜母细胞瘤视神经侵犯影像学与病理学检查一致性分析</ins>===</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">目的:研究基质金属蛋白酶-9 (matrix metalloproteinase-9,MMP-9) 和血管内皮生长因子(vascular endothelial growth factor,VEGF)在</del>[[视网膜母细胞瘤]]<del class="diffchange diffchange-inline">(retinoblastoma,</del>[[RB]]<del class="diffchange diffchange-inline">)中</del></div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">分析</ins>[[视网膜母细胞瘤]]<ins class="diffchange diffchange-inline">（</ins>[[RB]]<ins class="diffchange diffchange-inline">）视神经侵犯的影像学检查与临床病理学检查的一致性。</ins></div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>===<del class="diffchange diffchange-inline">视网膜母细胞瘤的临床表现和诊断</del>===</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>===<ins class="diffchange diffchange-inline">房水检测在视网膜母细胞瘤诊治中的应用</ins>===</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>[[视网膜母细胞瘤]]([[RB]])<del class="diffchange diffchange-inline">是一种好发于3岁以下儿童的高度恶性眼内肿瘤,其临床表现因就诊时疾病所处的阶段不同而不同.</del></div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">摘要 </ins>[[视网膜母细胞瘤]](<ins class="diffchange diffchange-inline">retinoblastoma，</ins>[[RB]])<ins class="diffchange diffchange-inline">是儿童最常见的眼内恶性肿瘤，由于其肿瘤组织松散，活检在[[RB]]中是禁忌。</ins></div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>===<del class="diffchange diffchange-inline">视网膜母细胞瘤基因治疗的研究进展</del>===</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>===<ins class="diffchange diffchange-inline">经后交通动脉进行眼动脉灌注化疗术治疗儿童视网膜母细胞瘤的多中心经验</ins>===</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">近年来[[视网膜母细胞瘤]]([[RB]])的综合治疗越来越受到重视.</del></div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">目的 探索经后交通动脉进行眼动脉灌注化疗（intra</ins>-<ins class="diffchange diffchange-inline">arterial chemotherapy via posterior communicating artery，p</ins>-<ins class="diffchange diffchange-inline">IAC）在</ins>[[视网膜母细胞瘤]]<ins class="diffchange diffchange-inline">（retinoblastoma，</ins>[[RB]]<ins class="diffchange diffchange-inline">）中的可行性与安全性。</ins></div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>&#160;</div></td><td colspan="2">&#160;</td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">===电穿孔介导质粒DNA导入视网膜母细胞瘤抑制肿瘤生长的实验研究===</del></div></td><td colspan="2">&#160;</td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">目的探讨电穿孔方法介导编码可溶性血管内皮细胞膜受体sFlk</del>-<del class="diffchange diffchange-inline">1和ExTek的真核表达质粒肿瘤内转移对[[视网膜母细胞瘤]]([[RB]])移植瘤生长的治疗效果及其作用机制.</del></div></td><td colspan="2">&#160;</td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>&#160;</div></td><td colspan="2">&#160;</td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">===姜黄素诱导视网膜母细胞瘤细胞株Hxo</del>-<del class="diffchange diffchange-inline">rb44细胞DNA损伤和细胞周期时相变化===</del></div></td><td colspan="2">&#160;</td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">目的 探讨姜黄素诱导</del>[[视网膜母细胞瘤]]<del class="diffchange diffchange-inline">(</del>[[RB]]<del class="diffchange diffchange-inline">)细胞株Hxo-rb44细胞DNA损伤和周期时相变化的关系.</del></div></td><td colspan="2">&#160;</td></tr> </table>

Admin http://120.24.161.253:5617/index.php?title=%E8%A7%86%E7%BD%91%E8%86%9C%E6%AF%8D%E7%BB%86%E8%83%9E%E7%98%A4-%E5%90%8C%E4%B9%89%E8%AF%8D-RB&diff=2005389&oldid=prev 2026-04-13T13:56:59Z

<p>修改1</p> <p><b>新页面</b></p><div>主实体：[[视网膜母细胞瘤]]，关系：[[同义词]] ，尾实体：[[RB]]<br /> <br /> ==关系介绍==<br /> 待补充<br /> <br /> ==来源==<br /> ===视网膜母细胞瘤分子生物学研究进展===<br /> [[视网膜母细胞瘤]](retinoblastoma, [[RB]])是婴幼儿最常见的眼内恶性肿瘤,一直被认为是研究肿瘤遗传学和肿瘤发病机理的理想模式.<br /> <br /> ===基质金属蛋白酶-9和血管内皮生长因子在视网膜母细胞瘤中的表达及其临床意义===<br /> 目的:研究基质金属蛋白酶-9 (matrix metalloproteinase-9,MMP-9) 和血管内皮生长因子(vascular endothelial growth factor,VEGF)在[[视网膜母细胞瘤]](retinoblastoma,[[RB]])中<br /> <br /> ===视网膜母细胞瘤的临床表现和诊断===<br /> [[视网膜母细胞瘤]]([[RB]])是一种好发于3岁以下儿童的高度恶性眼内肿瘤,其临床表现因就诊时疾病所处的阶段不同而不同.<br /> <br /> ===视网膜母细胞瘤基因治疗的研究进展===<br /> 近年来[[视网膜母细胞瘤]]([[RB]])的综合治疗越来越受到重视.<br /> <br /> ===电穿孔介导质粒DNA导入视网膜母细胞瘤抑制肿瘤生长的实验研究===<br /> 目的探讨电穿孔方法介导编码可溶性血管内皮细胞膜受体sFlk-1和ExTek的真核表达质粒肿瘤内转移对[[视网膜母细胞瘤]]([[RB]])移植瘤生长的治疗效果及其作用机制.<br /> <br /> ===姜黄素诱导视网膜母细胞瘤细胞株Hxo-rb44细胞DNA损伤和细胞周期时相变化===<br /> 目的 探讨姜黄素诱导[[视网膜母细胞瘤]]([[RB]])细胞株Hxo-rb44细胞DNA损伤和周期时相变化的关系.</div>

Admin